Zandelisib
Zandelisib is a potent and selective PI3K p110δ inhibitor (IC50 = 3.5 nM) with demonstrated antineoplastic activity. It is used in research for studying B-cell malignancies, both in vitro and in preclinical in vivo models, to investigate targeted oncology therapies.
Product Specifications
CAS Number
1401436-95-0
Product Name Alternative
Inhibit, ME 401, ME401, ME-401, Inhibitor, antineoplastic, 3-kinase, PWT143, PWT 143, PWT-143, p110δ, Phosphatidylinositol, Phosphoinositide 3-kinase, PI3K, PI3Kδ, Zandelisib
Field of Research
Signal Transduction
Purity
99.15% (May vary between batches)
Solubility
DMSO:33.33 mg/mL (57.8 mM) ;10% DMSO+90% Corn Oil:2 mg/mL (3.47 mM)
Smiles
CN1CCC (CC1) c1ccccc1CC (C) (C) Nc1nc (nc (n1) -n1c (nc2ccccc12) C (F) F) N1CCOCC1
Molecular Formula
C31H38F2N8O
Molecular Weight
576.68
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940315-100 1x 100 µL
Heparan Sulphate Proteoglycan (A7L6), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681744-100 1x 100 µL
Epstein-Barr Virus (LMP-1) (CS4), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB1971-500 1x 500 µL
LMO2 (B-Cell Marker) (LMO2/1971), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 